Recent literature has isolated certain NK cell subsets, including RAC1 high NK cells, which exhibit augmented tumor killing abilities in hepatocellular carcinoma (HCC) via regulating the STAT3-NKG2D axis [95]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.